Paper37538166
Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence.
Khan SR and 1 other. Asian J Urol, 2023. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence. Papers, record 37538166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37538166
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References129
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32111156 | Profiling the urinary microbiome in men with calcium-based kidney stones. | BMC Microbiol | 2020 | https://conductscience.org/library/papers/32111156 | PubMed |
| 2 | 8849402 | Lipids and membranes in the organic matrix of urinary calcific crystals and stones. | Calcif Tissue Int | 1996 | https://conductscience.org/library/papers/8849402 | PubMed |
| 3 | 29378952 | OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29378952 | PubMed |
| 4 | 16850024 | Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline. | Kidney Int | 2006 | https://conductscience.org/library/papers/16850024 | PubMed |
| 5 | 27143992 | The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/27143992 | PubMed |
| 6 | 25104802 | A nomogram for the prediction of kidney stone recurrence. | J Am Soc Nephrol | 2014 | https://conductscience.org/library/papers/25104802 | PubMed |
| 7 | 35586631 | Relationship Between Serum Testosterone Levels and Kidney Stones Prevalence in Men. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35586631 | PubMed |
| 8 | 22781098 | Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies. | Eur J Hum Genet | 2013 | https://conductscience.org/library/papers/22781098 | PubMed |
| 9 | 9280052 | Animal models of kidney stone formation: an analysis. | World J Urol | 1997 | https://conductscience.org/library/papers/9280052 | PubMed |
| 10 | 29241624 | The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury. | Kidney Int | 2018 | https://conductscience.org/library/papers/29241624 | PubMed |
| 11 | 23917291 | History of kidney stones and the risk of coronary heart disease. | JAMA | 2013 | https://conductscience.org/library/papers/23917291 | PubMed |
| 12 | 23840917 | NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys. | Oxid Med Cell Longev | 2013 | https://conductscience.org/library/papers/23840917 | PubMed |
| 13 | 18701630 | Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. | Am J Physiol Renal Physiol | 2008 | https://conductscience.org/library/papers/18701630 | PubMed |
| 14 | 19911680 | Risk factors for renal calcium stone formation in South African and European young adults. | Arch Ital Urol Androl | 2009 | https://conductscience.org/library/papers/19911680 | PubMed |
| 15 | 11992092 | Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. | J Urol | 2002 | https://conductscience.org/library/papers/11992092 | PubMed |
| 16 | 34799357 | Temporal Trends of Dietary Risk Factors after a Diagnosis of Kidney Stones. | Clin J Am Soc Nephrol | 2022 | https://conductscience.org/library/papers/34799357 | PubMed |
| 17 | 9989691 | Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. | Am J Clin Nutr | 1999 | https://conductscience.org/library/papers/9989691 | PubMed |
| 18 | 26924944 | Label-free proteomic methodology for the analysis of human kidney stone matrix composition. | Proteome Sci | 2016 | https://conductscience.org/library/papers/26924944 | PubMed |
| 19 | 24956378 | Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress. | Mol Endocrinol | 2014 | https://conductscience.org/library/papers/24956378 | PubMed |
| 20 | 19679672 | DASH-style diet associates with reduced risk for kidney stones. | J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19679672 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42928125 | Renal tubular injury-repair imbalance in calcium oxalate nephrolithiasis: mechanisms and therapeutic implications. | Mol Med | 2026 | https://conductscience.org/library/papers/42928125 | PubMed |
| 42164380 | ZJU index and prevalence of kidney stones in US adults: evidence for a threshold association from NHANES 2007-2018. | Transl Androl Urol | 2026 | https://conductscience.org/library/papers/42164380 | PubMed |
| 41543741 | Moroccan Pinus pinaster bark as a dual in vivo and in silico nephroprotective agent against nephrocalcinosis: toxicity and ADMET insights. | Urolithiasis | 2026 | https://conductscience.org/library/papers/41543741 | PubMed |
| 41179082 | Statin Therapy as a Preventive Strategy for Nephrolithiasis: A Review of Current Evidence. | Cureus | 2025 | https://conductscience.org/library/papers/41179082 | PubMed |
| 41019076 | Research progress on the mechanisms of interleukin and chemokine families in driving calcium oxalate nephrolithiasis formation. | Front Immunol | 2025 | https://conductscience.org/library/papers/41019076 | PubMed |
| 40788511 | Apoptosis, ferroptosis, necrosis, necroptosis and pyroptosis in the formation of calcium oxalate kidney stones. | Urolithiasis | 2025 | https://conductscience.org/library/papers/40788511 | PubMed |
| 40632241 | Oxidative stress, inflammation and kidney stones. | Urolithiasis | 2025 | https://conductscience.org/library/papers/40632241 | PubMed |
| 40082846 | Neutrophil to lymphocyte ratio in urolithiasis: a systematic review. | BMC Urol | 2025 | https://conductscience.org/library/papers/40082846 | PubMed |
| 39960517 | Recent developments in the study of cellular inflammation in the papillae of stone formers. | Urolithiasis | 2025 | https://conductscience.org/library/papers/39960517 | PubMed |
| 39951111 | Molecular insights into cell signaling pathways in kidney stone formation. | Urolithiasis | 2025 | https://conductscience.org/library/papers/39951111 | PubMed |
| 39917001 | N-acetyltransferase 10 regulates UNC-51-like kinase 1 to reduce tubular cell injury and kidney stone formation. | Cytojournal | 2024 | https://conductscience.org/library/papers/39917001 | PubMed |
| 39340639 | Two distinct phenotypes of calcium oxalate stone formers could imply different long-term risks for renal function. | Urolithiasis | 2024 | https://conductscience.org/library/papers/39340639 | PubMed |
| 37675156 | The effectiveness of citrates and pyridoxine in the treatment of kidney stones. | J Med Life | 2023 | https://conductscience.org/library/papers/37675156 | PubMed |
Genes41
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37538166
GET https://conductscience.org/api/papers/v1/37538166/references?page=2